Acima Private Wealth, LLC Bristol Myers Squibb CO Transaction History

Acima Private Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 28, 2024	SELL	$48.48 - $57.85 $5,041 - $6,016	-104 Reduced 34.21%	200 $10.3 Million
Q1 2023 Feb 28, 2024	BUY	$65.71 - $74.53 $6,833 - $7,751	104 Added 52.0%	304 $21.1 Million
Q2 2022 Feb 28, 2024	SELL	$72.62 - $79.98 $21,786 - $23,994	-300 Reduced 60.0%	200 $15.4 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $6,171 - $6,940	-104 Reduced 17.22%	500 $32,000
Q4 2020 May 14, 2021	SELL	$57.74 - $65.43 $5,658 - $6,412	-98 Reduced 13.96%	604 $37,000
Q3 2020 May 14, 2021	SELL	$57.43 - $63.64 $263,259 - $291,725	-4,584 Reduced 86.72%	702 $42,000
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $179,419 - $234,036	3,646 Added 222.32%	5,286 $339,000
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $73,996 - $88,232	1,640 New	1,640 $78,000

2,407

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $114B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Acima Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Acima Private Wealth, LLC with notifications on news.